成人支气管扩张症病因学诊断中国专家共识
中国支气管扩张症临床诊治与研究联盟及中华医学会呼吸病学分会感染学组组织专家,基于Delphi法经多轮讨论修订形成共识。共识分四部分:支扩定义及病因分类、病因学诊断程序、可治疗病因、其他病因,旨在提高中国支扩病因学诊断能力与疾病管理水平。
要点
- 共识采用Delphi法形成,聚焦成人支扩病因学诊断。
- 推荐胸部薄层CT用于支扩诊断及病因分类。
- 强调病史采集与病因学诊断流程,识别可治疗病因。
核心结论
- 共识旨在提高中国支扩病因学诊断准确性并优化疾病管理。
研究设计与样本
- 由中国支气管扩张症临床诊治与研究联盟和中华医学会呼吸病学分会感染学组专家基于Delphi法经多轮讨论修订形成。
主要发现
- 共识分为支扩定义及病因分类、病因学诊断程序、可治疗病因、其他病因四部分。
- 第一部分主要推荐胸部薄层CT用于支扩诊断及病因分类。
- 第二部分主要推荐支扩病史采集及病因学诊断方案。
- 第三部分主要推荐COPD继发支扩、哮喘所致支扩、弥漫性泛细支气管炎、变应性支气管肺曲霉病、结缔组织病相关支扩或胃食管反流病相关支扩的诊断。
- 第四部分主要推荐疑似原发性纤毛运动障碍相关支扩、囊性纤维化及先天性气道畸形的诊断。
关键数值与推荐
- 推荐胸部薄层CT用于支扩诊断及病因分类。
- 推荐对COPD继发支扩、哮喘所致支扩、弥漫性泛细支气管炎、变应性支气管肺曲霉病、结缔组织病相关支扩及胃食管反流病相关支扩进行诊断评估。
- 推荐对疑似原发性纤毛运动障碍相关支扩、囊性纤维化及先天性气道畸形进行诊断评估。
临床怎么用
- 临床应按共识推荐的病史采集和诊断流程评估成人支扩病因。
- 对可治疗病因如COPD、哮喘、变应性支气管肺曲霉病、结缔组织病及胃食管反流病相关支扩应识别并管理。
- 对疑似原发性纤毛运动障碍、囊性纤维化及先天性气道畸形应按照共识推荐进行诊断评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bronchiectasis is a highly heterogeneous chronic airway disease for which accurate etiological diagnosis is crucial for effective management. A group of experts from the China Bronchiectasis Alliance and the Infection Assembly of the Chinese Thoracic Society conducted a comprehensive review of recent research into the etiology of bronchiectasis. Using the widely accepted Delphi methodology, the experts reached a consensus on the etiological diagnosis of bronchiectasis through multiple rounds of discussion and revision. The consensus is divided into four sections: the definition and classification of the etiology of bronchiectasis, the etiological diagnostic procedures for bronchiectasis, the treatable causes of bronchiectasis, and other causes of bronchiectasis. The ultimate goal of this consensus is to improve the diagnostic accuracy and optimize the management of bronchiectasis in China. The main recommendations of Section 1 focused on chest thin-section computed tomography (CT) for the diagnosis of bronchiectasis and the etiological classification. The main recommendations of Section 2 focused on the medical history collection for bronchiectasis and the etiological diagnostic protocol for bronchiectasis. The main recommendations of Section 3 focused on the recommendations of the diagnosis of bronchiectasis secondary to COPD, the diagnosis of bronchiectasis due to asthma, diffuse pan-bronchiolitis, allergic bronchopulmonary aspergillosis, connective tissue disease (CTD)-related bronchiectasis or gastroesophageal reflux disease (GERD)-related bronchiectasis. The main recommendations of Section 4 focused on suspected primary ciliary dyskinesia (PCD)-associated bronchiectasis, cystic fibrosis and the diagnosis of congenital airway malformations. 支气管扩张症(简称支扩)是一种异质性很强的慢性气道疾病,其病因诊断对于疾病管理具有重要作用。中国支气管扩张症临床诊治与研究联盟、中华医学会呼吸病学分会感染学组组织专家,充分评估了支扩病因诊断领域最新的研究结果,基于国际通用的Delphi程序,经过多次会议讨论和修订,最终形成了支扩病因学诊断的专家共识。本共识分为四个部分:支扩的定义及病因分类、支扩的病因学诊断程序、支扩的可治疗病因、支扩的其他病因。希望通过本共识,助力提高中国支扩病因学诊断能力和疾病管理水平。.
引用
- [Chinese expert consensus on the etiological diagnosis of adult bronchiectasis]. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 39406539. doi:10.3760/cma.j.cn112147-20240606-00315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。